The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Migraine Medication Attributes Important for Patient Compliance: Concerns About Side Effects May Delay Treatment
Abstract
Objectives.—To determine the level of concern among migraineurs about migraine prescription medication tolerability and adverse effects and the impact of these concerns on their self‐management of migraine. Methods.—Self‐completion questionnaires were mailed from the National Family Opinion household panel to a prequalified sample of 4000 adults (aged 18 years or older) who reported severe headache and migraine. Those who met the International Headache Society symptom criteria for migraine and reported use of prescription medication to treat their migraines were included in the descriptive analysis. Results.—A total of 2444 (61%) sufferers of severe headache/migraine returned a completed survey, and 56% of these (n = 1160) met the target criteria for the study. Of those meeting the criteria, pain relief and speed of onset were important product attributes for 75% to 77% of sufferers, and the absence of adverse effects was important to over 40%. Two‐thirds of sufferers specifically had delayed or avoided taking a current prescription medication because of concerns about adverse effects. These concerns led to a delay in taking medication in 37% of treated migraine episodes and to medication avoidance in 44% of untreated attacks during the previous 6 months, resulting in more intensive and longer duration of pain, the need to rest and cancel social activities, and suboptimal performance. Almost 8 of 10 (79%) sufferers showed an interest in trying a novel product with similar efficacy but fewer adverse effects than other prescription migraine medications. Conclusions.—Adverse effects are an important factor in migraine management, and concern about adverse effects significantly affected patient compliance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Cited by
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
Lipton, R. B., Croop, R., Stock, E. G., Stock, D. A., Morris, B. A., Frost, M., Dubowchik, G. M., Conway, C. M., Coric, V., & Goadsby, P. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811090 · Cited by 398
Behavioral medicine for migraine
Buse, D. C., & Andrasik, F. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.01.003 · Cited by 113
Dudeney, J., Sharpe, L., McDonald, S., Menzies, R. E., & McGuire, B. (2022) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.14260 · Cited by 26
Metadata
- Authors
- Gallagher, R. M., & Kunkel, R.
- Venue
- Headache: The Journal of Head and Face Pain
- Publisher
- Wiley
- Published
- 2003-01
- Volume
- 43
- Issue
- 1
- Pages
- 36-43
- ISSN
- 0017-8748 (ISSN-L)
- 1526-4610
- OpenAlex
- W2022575186
- Cited by
- 190
- References
- 1
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Migraine Medication Attributes Important for Patient Compliance: Concerns About Side Effects May Delay Treatment. https://app.cochat.ai/papers/10.1046/j.1526-4610.2003.03006.x
- The paper
- Gallagher, R. M., & Kunkel, R. (2003). Migraine Medication Attributes Important for Patient Compliance: Concerns About Side Effects May Delay Treatment. Headache: The Journal of Head and Face Pain. https://doi.org/10.1046/j.1526-4610.2003.03006.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.